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The role of plasma lysozyme of normal healthy sub-
jects (NHS, n = 12) and active pulmonary tuberculo-
sis (ATB) patients (n = 15) on the innate immune 
mechanism was studied by the binding activity of 
lysozyme on live Mycobacterium tuberculosis. Plasma 
samples of NHS and ATB patients treated with live 
M. tuberculosis for 4 h and 24 h time points showed a 
significant decrease in the plasma lysozyme level 
when compared to the untreated samples (4 h, 
P < 0.001; 24 h, P < 0.001). Pretreatment of live M. 
tuberculosis with plasma of NHS and ATB patien s 
showed a trend in the reduction of viability of live M.
tuberculosis. Moreover, M. tuberculosis pretreated 
plasma of NHS showed a trend towards an increased 
spontaneous as well as antigen-induced lymphocyte 
response when compared to ATB plasma. The enzy-
matic action of the lysozyme and other enzymes on 
the cell wall may induce M. tuberculosis to release 
some antigenic components which may be immuno-
genic and induce lymphocyte proliferation. The pre-
sent study suggests that lysozyme and other enzymes 
may play an important role in the first line defence, 
i.e. the innate immunity, against M. uberculosis in-
fection. 
 
LYSOZYME is one of the hydrolytic enzymes of the ly-
sosomal compartment of phagocytic cells such as 
monocytes/macrophages and neutrophils1. Lysozyme is 
secreted into the extracellular compartment and has 
been shown to be bactericidal. This enzyme along with 
other enzymes and proteins is involved in the first line 
of defence against any pathogenic infection. The bio-
logic importance of lysozyme lies in its ability to hydro-
lyse the polysaccharide portion of bacterial cell walls. 
Lysozyme causes lysis of Gram-positive and some 
Gram-negative bacteria by specific cleavage of the b1-4 
linkage between N-aceytylglucosamine and N-acetyl- 
muramate in the peptidoglycan backbone of bacterial 
cell walls2. Lysozyme has been shown to specifically 
bind glucose-modified proteins bearing advanced glyca-
tion end-products (AGEs). Exposure to AGE-modified 
proteins has been shown to inhibit the enzymatic and 
bactericidal activi y of lysozyme3. 
 It has been shown that binding of lysozyme with 
lipopolysaccharide (LPS) affects the enzymatic activity 
of lysozyme as well as the immunostimulatory effect of 
 
 
*For correspondence. (e-mail: icmrtrc@md3.vsnl.net.in) 
LPS4,5. Since, carbohydrate moieties similar to LPS 
such as lipoarabinomannan and lipomannan have been 
shown in the cell wall of Mycobacterium tuberculosis, 
an attempt was made to find out whether lysozyme 
binds to live M. tuberculosis, and if so, whether binding 
of lysozyme affects the viability of M. tuberculosis.  
 Increased lysozyme level has been observed in myco-
bacterial diseases6–8. Although lysozyme levels have no 
diagnostic value p r se in tuberculosis, this enzyme has 
been suggested as a non-specific diagnostic marker 
along with antibody levels in tuberculosis8,9. Since 
plasma lysozyme plays an important role in innate immu-
nity, the goal of the present study was to find out the effect 
of plasma lysozyme on live M. tuberculosis. Moreover, the 
modulatory effect of plasma samples exposed to live M. 
tuberculosis on lymphocyte response has also been studied. 
 Patients who were sputum-positive for M. tuberculo-
sis by smear and culture were known as active pulmo-
nary tuberculosis (ATB) patients. Plasma samples of 
ATB patients (n = 15) and normal healthy subjects 
(NHS, n = 12) were used. These plasma samples were 
stored frozen at –20°C until required. 
 Based on our preliminary experiments (data not 
shown) on different concentrations (0.5, 1, 2 mg/100ml) 
of heat killed M. tuberculosis H37Rv, live M. tuberculo-
sis H37Rv and Micrococcus lysodeikticus (Sigma 
Chemical Co, St. Louis, USA), 2 mg/100 ml plasma was 
selected for further experiments. Since, M. lysodeikticus 
is rich in polysaccharide moiety, this organism was used 
as a positive control. Two mg wet weight of live M. 
tuberculosis containing approximately 1.2–1.6 ´ 108 
viable bacilli was suspended in 1 ml sterile distilled 
water. The suspension was taken in an 1.5 ml eppendorf 
tube and centrifuged for 5 min at 16,000 rpm. The su-
pernatant was removed completely using a micropipette. 
To the packed volume, 100 ml plasma sample of either 
ATB patient or NHS was added, mixed well and incu-
bated at 37°C for 4 h and 24 h. Similarly, M. lysodeikti-
cus (positive control) was also taken and incubated with 
100 ml plasma sample for 4 h and 24 h. Plasma samples 
without M. tuberculosis or Micrococcus erved as con-
trols. After 4h and 24 h of incubation, the samples were 
centrifuged at 16,000 rpm for 5 min to pellet out M.
tuberculosis and M. lysodeikticus and the plasma sam-
ples were checked for their lysozyme level. The stimu-
latory or suppressive effect of M. tuberculosis-treated 
plasma samples on the lymphocyte response was stud-
ied either with or without M. tuberculosis culture fil-
trate antigen. For the bactericidal activity, 3 ´ 106 
bacilli per 100 ml of plasma of either ATB patients or 
NHS were taken, incubated for 4 h and 24 h and packed 
by centrifugation. Lysozyme level was also etimated. 
The packed bacilli were washed twice in sterile di tilled 
water and resuspended in 500 ml of distilled water. Se-
rial 10-fold dilutions were made from this supension 
and plated on Middlebrook 7H11 agar plates in tripli-
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cate to find out the viable counts, and the exact colony 
forming units (CFU) were determined after 15 days of 
incubation at 37oC. Lysozyme level was estima ed by 
single radial diffusion as described in detail earlier7,10. 
 M. tuberculosis H37Rv strain (TMC201) maintained 
by periodic passaging through guinea pigs and subcul-
tured in Lowenstein–Jensen (L–J medium) was used. 
Approximately two-thirds of 3 mm external diameter 
(24 SWG wire loop) of bacillary mass from the L-J
slope was taken and transferred to 0.2 ml of sterile dis-
tilled water in a 7 ml Bijou bottle containing 1–3 mm 
glass beads. This bacillary mass was considered to con-
tain approximately about 4 mg wet weight of the organism. 
The Bijou bottle was kept in a mechanical shaker for a few 
minutes to produce a uniform suspension. To this suspen-
sion, 0.8 ml of sterile distilled water was added and mixed 
well and a bacillary count was made with a Thoma counter. 
 Heparinized (20 units/ml) peripheral blood samples 
drawn from NHS (n = 9) were subjected to ficoll-
hypaque density gradient centrifugation as described by 
Boyum11 and used for lymphoproliferative response. 
Lymphocytes were cultured/stimulated either with the
plasma samples treated with live M. tuberculosis alone 
or plasma samples treated with live M. tuberculosis and 
M. tuberculosis culture filtrate antigen (10 mg/ml)12. 
 The results are expressed as arithmetic mean ± stan-
dard error (SE). Statistical significa ce was done using 
Student’s t test. 
 A decreased plasma lysozyme level was observed 
with plasma samples of both ATB patients and control 
subjects treated with either M. lysodeikticus, heat-killed 
or live M. tuberculosis than in untreated plasma sa-
ples. The decrease was proportional to the dose of the 
bacteria used (0.5, 1  and 2 mg/100 ml of plasma, data 
not shown). 
 Plasma samples pretreated with live M. tuberculosis 
(2 mg/100 ml) for 4 h and 24 h showed a significant de-
crease in the lysozyme levels of NHS (4 h P < 0.05; 
24 h, P < 0.001) and ATB patients (4 h, P < 0.001; 24 h, 
P < 0.001; Figure 1). Live M. tuberculosis treated with 
plasma samples of either NHS or ATB patients showed 
decreased CFU (in log counts) both at 4 h and 24 h (0 h: 
PBS-CFU 6.5; 4 h: NHS-CFU 5.6 ± 0.1; ATB-CFU 
5.7 ± 0.04; 24 h: NHS-CFU 5.0 ± 0.0; ATB-CFU 
5.2 ± 0.1). 
 Plasma samples of ATB patients and NHS pretreated 
with live M. tuberculosis showed a trend towards a 
stimulatory effect on the lymphocyte response. Sponta-
neous lymphocyte response and the antigen-i duced 
lymphocyte response of NHS were augmented by the 
plasma of NHS-treated with live M. tuberculosis for 
4 h. Similar treatment of plasma samples with live M. 
tuberculosis for 24 h showed a moderate stimulatory 
effect on the lymphocyte response (Figure 2). Such an 
increase was not observed with plasma samples of ATB 
patients. 
 
Figure 1. Binding activity of plasma lysozyme of normal healthy 
subjects (NHS) and active-TB (ATB) patients on M. tuberculosis. 
Each bar represents the arithmetic mean ± standard error (S.E.). 
Plasma lysozyme level before and after treatment with M. tuberculo-
sis – NHS: 4 h, P < 0.05; 24 h, P < 0.001; ATB: 4h, P < 0.001; 24 h, 




Figure 2. Immunomodulatory effect of M. tuberculosis pretreated 
plasma of normal healthy subjects (NHS) and active-TB (ATB) 
patients on spontaneous as well as M. tuberculosis culture filtrate 
antigen-induced lymphocyte response of normal subjects. Lympho-
cyte response was studied in 9 healthy subjects. Each bar represents 
mean ± S.E. Cells, peripheral blood mononuclear cells; Ag, M.
tuberculosis culture filtrate antigen; M.tb plasma, Plasma pretreated 
with M. tuberculosis. 
 
 
 Plasma of NHS and ATB patients pretreated with live 
M. tuberculosis showed a significant reduction in the 
plasma lysozyme level. This shows that plasma ly-
sozyme binds to live M. tuberculosis. Increased ly-
sozyme level in any infectious disease, including 
mycobacterial diseases, is well established. The action 
RESEARCH COMMUNICATIONS 
 
CURRENT SCIENCE, VOL. 81, NO. 2, 25 JULY 2001 203
of lysozyme is through binding and cleavage of cell 
wall polysaccharide by the enzymatic action. Even 
though M. tuberculosis cell wall contains mainly cord 
factor and other lipids, it also contains polysaccharides 
such as lipoarabinomannan and lipomannan. In ATB, 
the bacterial load harbouring in the system may be high, 
which may induce the system to produce more ly-
sozyme to encounter the M. tuberculosis pathogen. 
 In the present study, a trend towards a decreased CFU 
of M. tuberculosis pretreated with plasma of either NHS 
or ATB patients was observed. One of the mechanisms 
for this decreased CFU may probably be due to the 
damage/injury caused by the enzymatic action of ly-
sozyme on the carbohydrate moieties of the cell wall of 
M. tuberculosis, along with other enzymes and proteins 
of the plasma (which may also be detrimental to M. tu-
berculosis). 
 The stimulatory effect of 4h plasma pretreated with 
live M. tuberculosis may be due to the release of some 
of the carbohydrate moieties such as lipoarabinoman-
nan, lipomannan and some other cell wall components 
due to the action of lysozyme and other enzymes on live 
M. tuberculosis, which may be immunogenic and stimu-
latory to lymphocytes. 
 The present study suggests that lysozyme in the 
plasma as well as in cells/tissues may be detrimental to 
M. tuberculosis and to other pathogens. Moreover, ly-
sozyme along with other host enzymes and proteins may 
play an important role in innate immunity agai st M. 
tuberculosis nfection. 
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Moderate to intense blooms of the dinoflagellate 
Noctiluca scintillans occurred in Port Blair Bay, An-
damans during June and July of 2000. The blooms 
occurred thrice in succession after short periods of 
wa ing. The bloom that came about second in the 
sequence, between 11 and 20 July 2000, gave us an 
opportunity to investigate the changes in water 
c aracteristics associated with the event. Results in-
dicate that variations in dissolved oxygen concentra-
tion were fairly small, whilst nutrient levels and 
plankton compositions were dramatically altered. 
Primarily, the bloom led to exclusion of other phyto-
plankton, also limiting zooplankton prevalence to 
essentially copepods. The bloom resulted in excep-
tionally high levels of chlorophyll c, which exceeded 
levels of chlorophyll a by several folds. Nutrient lev-
els were characterized by decrease of nitrate during 
active periods of the bloom, and sharp increase in 
phosphate, particularly during the waning phase. 
 
BLOOMS of the dinoflagellate Noctiluca scintillans have 
been reported from Indian waters by Prasad1 in Palk 
Bay, Subrahmanyan2 d Katti et al.3 in the Arabian 
Sea, Sargunam, Rao and Nair4 in Kalpakkam coastal 
waters and more recently, by Naqvi and coworkers5 off 
Cochin. In only one case has fish kill been reported5, 
although the authors were cautious not to overrate the 
severe fish mortality as a direct consequence of the 
Noctiluca bloom. 
 An intense bloom of Noctiluca was first noticed in 
the waters of Port Blair Bay during the second week of 
June 2000. The bloom imparted light to the vivid green 
colour of the coastal waters. The bloom persisted for 
several days, waning eventually by the end of the 
month. In course of time, the bloom reappeared twice 
during July 2000. This communication addresses the 
changes in coastal water characteristics associated with 
the event, with particular emphasis on the bloom that 
occurred between 11 and 20 July 2000. 
 The Port Blair Bay extends as a narrow stretch in a 
northeast to southwest direction (Figure 1). Six station 
locations spread over the entire Bay, as indicated in the 
figure, were considered for the primary sampling done 
on 12 June 2000. Further investigations were limited to 
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